The Patent Finder

Acasti Pharma U.S., Inc.

9 patents currently held · Updated Nov 16, 2026
5 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.

Recorded as renamed to Grace Therapeutics Inc. (2025)

0
Ending by 2030
Jan 2037
Next term end

When these terms end

Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
  • 1 fee due Jul 2, 2027
    The maintenance fee for Therapeutic composition of intranasal lidocaine (US 11,857,520) comes due Jul 2, 2027. Unpaid by Jan 3, 2028, it lapses early.

Which patents, and when each one lapses · Pro

Recent changes

Nothing was recorded against this company's patents in the last 90 days.

Patents held now

Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.

Showing 1 to 9 of 9

PatentTitleStatus Expires Confidence
US 11,291,672Betamethasone oral spray formulation and method of use to treat ataxia
In force
 · From the USPTO record
In forceFrom the USPTO record
US 10,092,553Stable nimodipine parenteral formulation
In force
 · From the USPTO record
In forceFrom the USPTO record
US 10,092,557Stable nimodipine parenteral formulation
In force
 · From the USPTO record
In forceFrom the USPTO record
US 10,765,671Stable nimodipine parenteral formulation
In force
 · From the USPTO record
In forceFrom the USPTO record
US 10,799,486Stable nimodipine parenteral formulation
In force
 · From the USPTO record
In forceFrom the USPTO record
US 11,433,062Stable nimodipine parenteral formulation
In force
 · From the USPTO record
In forceFrom the USPTO record
US 12,059,415Stable Nimodipine Parenteral Formulation
In force
 · Medium confidence
In forceMedium confidence
US 12,285,420Stable Nimodipine Parenteral Formulation
In force
 · Medium confidence
In forceMedium confidence
US 11,857,520Therapeutic composition of intranasal lidocaine
In force
 · From the USPTO record
In forceFrom the USPTO record
Also on record, not counted in the 9: 5 patents in force now held by others · 2 lapsed for an unpaid fee. List them

Sources and methods

Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.

Published applications

US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.

2 no status recorded

List them

The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited